Floatz logo

ADENOSINE, N-CYCLOPENTYL-

Neoplasm Metastasis

Japan Clinical Oncology GroupSmall moleculePhase 3Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
41/ 100
Competitive Position
73/ 100

Competitive context

171 Active assets in the Neoplasm Metastasis cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
Ruijin Hospital
Phase 4BBB
Eloxatin
Ruijin Hospital
Phase 4BBB
Irinotecan
Eli Lilly and Company
Phase 4BBB
DEXAMETHASONE
Janssen Research & Development, LLC
Phase 2BBB
Ipilimumab
7 Hills Pharma, LLC
Phase 3BB

View all 50 →

Same molecule, other indications

ADENOSINE, N-CYCLOPENTYL- is also rated in:

Refractory Diffuse Large B-cell LymphomaDormant
CCC
Indicative ·
50 / 100
View asset →
relapsed/refractory diffuse large B-cell lymphomaDormant
CCC
Indicative ·
50 / 100
View asset →
breast cancerDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →